MD
$19.62
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications wi...
Recent News
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Investors Continue to Hold Pediatrix Medical Stock
Favorable payer mix, higher neonatology acuity and prudent acquisitions will support MD's growth, while shares look undervalued versus industry peers.
1 Unpopular Stock That Should Get More Attention and 2 We Question
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Pediatrix Buybacks And Return To Profitability Recast Shareholder Prospects
Pediatrix Medical Group (NYSE:MD) reported its full year and fourth quarter earnings alongside confirmation of substantial share repurchases. The company completed significant buybacks across multiple authorized programs, including activity tied to a 2025-announced repurchase plan. Management also reported a transition to profitability for the full year, marking a key update in the company’s recent financial profile. Pediatrix focuses on physician services for newborn, maternal fetal and...
Is Pediatrix Medical Group (MD) Pricing Reflect Its DCF And P/E Valuation Gap
If you are trying to figure out whether Pediatrix Medical Group is genuinely good value or just looks cheap on the surface, this breakdown is for you. The share price recently closed at US$19.85, with returns of 0.6% over 7 days, a 7.2% decline over 30 days, a 6.8% decline year to date, a 36.8% gain over 1 year and 31.5% over 3 years, while sitting 28.3% lower over 5 years. Recent coverage has focused on Pediatrix Medical Group's position in the US healthcare space and how investors are...